http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0308347-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-12
filingDate 2003-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c25791d0e135320ba06000f825757ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75051cb8b358982e5dc03efedcd7775a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13e8988ebeb853c2d52f2c68970cc4b8
publicationDate 2005-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0308347-A
titleOfInvention Process for the manufacture of chiral 1,4-disubstituted piperazines
abstract "PROCESS FOR MANUFACTURING CHIRAL 1,4-DISSUBSTED PIPERAZINES". The present invention relates to a process for the stereoselective preparation of novel chiral nitrogen mustard derivatives useful in the synthesis of optically active 1,4-disubstituted piperazines of formula (I) wherein R, Ar, and Q are defined as shown herein. and intermediate compounds therefor. 1,4-Disubstituted piperazines act as 5HT1A receptor binding agents useful in the treatment of Central Nervous System (CNS) disorders.
priorityDate 2002-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID471533
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID431581
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID487230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546492
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24473
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100001828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4033
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378605
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407137
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15550

Total number of triples: 39.